These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15631774)

  • 1. [Multicenter, randomized, positive-controlled clinical study for the effects of nerotropin on diabetic neuropathy].
    Ning G; Zou DJ; Liu W; Xing HL; Zhang W; Zhao YJ; Lu J; Xu H; Jin J
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1785-7. PubMed ID: 15631774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus.
    Kadiroglu AK; Sit D; Kayabasi H; Tuzcu AK; Tasdemir N; Yilmaz ME
    J Diabetes Complications; 2008; 22(4):241-5. PubMed ID: 18413214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical observation of combined therapeutic effect of prostaglandin E1 and mecobalamin on diabetic peripheral neuropathy].
    Zhu XP; Zhou ZG
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):343-4. PubMed ID: 12536730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.
    Thisted RA; Klaff L; Schwartz SL; Wymer JP; Culligan NW; Gerard G; Pope LE; Berg JE
    Clin Ther; 2006 Oct; 28(10):1607-18. PubMed ID: 17157116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.
    Casellini CM; Barlow PM; Rice AL; Casey M; Simmons K; Pittenger G; Bastyr EJ; Wolka AM; Vinik AI
    Diabetes Care; 2007 Apr; 30(4):896-902. PubMed ID: 17392551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of the effect of buflomedil on peripheral neuropathy in diabetic patients].
    Zhou M; Lei MX
    Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):239-40. PubMed ID: 12536693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report.
    Valensi P; Le Devehat C; Richard JL; Farez C; Khodabandehlou T; Rosenbloom RA; LeFante C
    J Diabetes Complications; 2005; 19(5):247-53. PubMed ID: 16112498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
    Vinik AI; Bril V; Kempler P; Litchy WJ; Tesfaye S; Price KL; Bastyr EJ;
    Clin Ther; 2005 Aug; 27(8):1164-80. PubMed ID: 16199243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study.
    Hsieh SH; Lin JD; Cheng HY; Ho C; Liou MJ
    Clin Ther; 2006 Sep; 28(9):1318-26. PubMed ID: 17062305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sixty-one patients with diabetic peripheral neuropathy treated by tongluo yangyin recipe.
    Xu WG
    Chin J Integr Med; 2007 Sep; 13(3):190-4. PubMed ID: 17898949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise training can modify the natural history of diabetic peripheral neuropathy.
    Balducci S; Iacobellis G; Parisi L; Di Biase N; Calandriello E; Leonetti F; Fallucca F
    J Diabetes Complications; 2006; 20(4):216-23. PubMed ID: 16798472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy.
    Bastyr EJ; Price KL; Bril V;
    Clin Ther; 2005 Aug; 27(8):1278-94. PubMed ID: 16199253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.
    Williams GW; Kivitz AJ; Brown MT; Verburg KM
    Clin Ther; 2006 Feb; 28(2):204-21. PubMed ID: 16678642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 2-week, multicenter, randomized, double-blind, double-dummy, add-on study of the effects of titration on tolerability of tramadol/acetaminophen combination tablet in Korean adults with knee osteoarthritis pain.
    Choi CB; Song JS; Kang YM; Suh CH; Lee J; Choe JY; Lee CK; Shim SC; Chung WT; Song GG; Kim HA; Ji JD; Nam EJ; Park SH; Hong YH; Sheen DH; Lim MK; Seo YI; Sung YK; Kim TH; Lee JT; Bae SC
    Clin Ther; 2007 Jul; 29(7):1381-9. PubMed ID: 17825689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipo-prostaglandin E1 in combination with steroid therapy is effective for treatment of sudden sensorineural hearing loss in Korean patients with Type 2 diabetes.
    Ahn JH; Kim TY; Kim YJ; Han MW; Yoon TH; Chung JW
    Diabet Med; 2006 Dec; 23(12):1339-43. PubMed ID: 17116185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Tolrestat on oesophageal transit time and cholecystic motility in type 2 diabetic patients with asymptomatic diabetic neuropathy.
    Fabiani F; De Vincentis N; Staffilano A
    Diabete Metab; 1995 Dec; 21(5):360-4. PubMed ID: 8586153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of oral prostaglandin analogue on painful diabetic neuropathy: a double-blind, randomized, controlled trial.
    Shin S; Kim KJ; Chang HJ; Lee BW; Yang WI; Cha BS; Choi D
    Diabetes Obes Metab; 2013 Feb; 15(2):185-8. PubMed ID: 22974254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side effects of ketamine in the long-term treatment of neuropathic pain.
    Cvrcek P
    Pain Med; 2008 Mar; 9(2):253-7. PubMed ID: 18298710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study.
    Rauck RL; Shaibani A; Biton V; Simpson J; Koch B
    Clin J Pain; 2007 Feb; 23(2):150-8. PubMed ID: 17237664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P;
    Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.